COURTNEY GIBSON: Open Payments
NPI 1285292003 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$513 in 23 payments from 11 companies in 2025. Trend: 2023 $256 · 2024 $434 · 2025 $513
Food & beverage: $513
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $228 |
| Astellas Pharma US Inc | 4 | $95 |
| PFIZER INC. | 2 | $31 |
| Pharmacosmos Therapeutics Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| SANOFI-AVENTIS U.S. LLC | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| Boston Scientific Corporation | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: AIRSUPRA, FARXIGA, Veozah, NURTEC ODT, MONOFERRIC, QULIPTA, REXULTI, TZIELD.
Industry payments across OK — which companies pay providers there.
